Drug-induced movement disorder education program

The New York Legislature approved file A01017 ("Drug-induced movement disorder education program"), by a recorded vote of 208 to 0. Last action: February 14, 2025.

New York file A01017, before the New York Legislature. Passed as of 2025-02-14.

What it does

Patients learn risks of drug-induced movement disorders Patients and doctors gain access to state-funded educational materials about movement disorders caused by medications, helping earlier recognition and management of symptoms like tremors or involuntary movements.

The bigger picture

Healthcare system improves awareness of medication side effects Clinicians benefit from standardized outreach materials, potentially reducing misdiagnosis of drug-induced movement disorders as primary neurological conditions and improving treatment coordination across providers.

How they voted

Yes (208)

Did not vote / other (5)

Read the official record for A01017

See everything up for a vote · This week in New York · See what we have filed with the clerk